Quality Assessment in Acute Stroke Care

Acute Ischemic Stroke Clinical Trial

— QuASt  

Official title:

Quality of Acute Stroke Care Evaluated With a Clinical Pathway on a 16 Bed Stroke Unit - a Prospective Trial

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT00574262
• Other study ID #: ClinPathStroke
• Status: Recruiting
• Phase: N/A
• First received: November 23, 2007
• Last updated: January 12, 2010
• Start date: October 2007
• Est. completion date: April 2009

Study information

• Verified date: November 2007
• Source: University Hospital Muenster
• Contact: Wolf Rüdiger Schäbitz, MD
• Phone: 0049-251-8345235
• Email: schabitz[@]uni-muenster.de
• Is FDA regulated: No
• Health authority: Germany: Federal Institute for Drugs and Medical Devices
• Study type: Observational

Clinical Trial Summary

The purpose of the study is to evaluate the quality of care on a 16 bed stroke unit by using a new developed clinical pathway.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 400
• Est. completion date: April 2009
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• admission to the stroke unit of the university hospital in Muenster, Germany

• acute ischemic stroke or transient ischemic attack

Exclusion Criteria:

• intracerebral haemorrhage

• neurological symptoms due to other pathology than acute ischemic stroke or transient ischemic attack

• intraarterial thrombolysis

• necessity of artificial ventilation

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

• Acute Ischemic Stroke
• Stroke

Locations

Country	Name	City	State
Germany	Department of Neurology, University Hospital of Muenster	Muenster

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital Muenster

Country where clinical trial is conducted

Germany, 

References & Publications (3)

Heuschmann PU, Biegler MK, Busse O, Elsner S, Grau A, Hasenbein U, Hermanek P, Janzen RW, Kolominsky-Rabas PL, Kraywinkel K, Lowitzsch K, Misselwitz B, Nabavi DG, Otten K, Pientka L, von Reutern GM, Ringelstein EB, Sander D, Wagner M, Berger K. Development and implementation of evidence-based indicators for measuring quality of acute stroke care: the Quality Indicator Board of the German Stroke Registers Study Group (ADSR). Stroke. 2006 Oct;37(10):2573-8. Epub 2006 Sep 7. Erratum in: Stroke. 2007 Jan;38(1):206. Kolominisky-Rabas, Peter L [corrected to Kolominsky-Rabas, Peter L]. — View Citation

Kwan J. Care pathways for acute stroke care and stroke rehabilitation: from theory to evidence. J Clin Neurosci. 2007 Mar;14(3):189-200. Review. — View Citation

Taylor WJ, Wong A, Siegert RJ, McNaughton HK. Effectiveness of a clinical pathway for acute stroke care in a district general hospital: an audit. BMC Health Serv Res. 2006 Feb 23;6:16. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	frequency of patients monitored according to the specific german procedure standard (OPS-code 8-981) (preset target 90 - 95 %)		duration of stay on stroke unit	No
Secondary	frequency of stroke been classified according to the TOAST criteria (preset target 55 - 65 %)		duration of stay on stroke unit	No
Secondary	frequency of initiated or improved antithrombotic secondary prevention (preset target 90 - 95 %)		duration of stay on stroke unit	No
Secondary	frequency of initiated or improved statin therapy (preset target 40 - 50 %)		duration of stay on stroke unit	No
Secondary	frequency of totally completed clinical diagnostics regarding the etiology of the stroke (preset target 60 -70 %)		duration of stay on stroke unit	No
Secondary	frequency of initiated or improved antihypertension therapy and reduction of systolic and diastolic blood pressure by more than 10 mmHg (preset target 60 - 70 %)		duration of stay on stroke unit	No
Secondary	frequency of a reduction on the NIH-SS by at least two points (preset target 50 - 60 %)		duration of stay on stroke unit	No